Optimal duration of antiviral treatment in patients with gastrointestinal cytomegalovirus disease at a low and high risk of relapse

We evaluated the association between antiviral treatment duration and relapse of gastrointestinal (GI) cytomegalovirus (CMV) disease by analyzing the risk factors for relapse. Patients who were diagnosed with GI CMV disease at a tertiary hospital from January 2008 to April 2019 were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Kyung Hwa, Jung, Jiwon, Kim, Min Jae, Chong, Yong Pil, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Kim, Sung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735784/
https://www.ncbi.nlm.nih.gov/pubmed/35029881
http://dx.doi.org/10.1097/MD.0000000000028359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735784/
https://www.ncbi.nlm.nih.gov/pubmed/35029881
http://dx.doi.org/10.1097/MD.0000000000028359

Ejemplares similares